Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response.

Hoellinger, Baptiste; Danion, François; Hansmann, Yves; Schramm, Frederic; Ruch, Yvon

Hoellinger, Baptiste; Danion, François; Hansmann, Yves; Schramm, Frederic; Ruch, Yvon.

Hoellinger B; Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: baptiste.hoellinger@chru-strasbourg.fr.
Danion F; Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Hansmann Y; Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Schramm F; Department of Bacteriology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Ruch Y; Department of Infectious and Tropical Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Clin Microbiol Infect ; 29(6): 812-813, 2023 06.

Article in English | MEDLINE | ID: covidwho-20236850

Subject(s)

Cephalosporins; Gram-Negative Bacterial Infections; Humans; Cephalosporins/pharmacology; Cephalosporins/therapeutic use; Gram-Negative Bacteria; Anti-Bacterial Agents/pharmacology; Anti-Bacterial Agents/therapeutic use; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Gram-Negative Bacterial Infections/drug therapy; Gram-Negative Bacterial Infections/microbiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cephalosporins / Gram-Negative Bacterial Infections Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google